vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and Ramaco Resources, Inc. (METC). Click either name above to swap in a different company.
Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $121.0M, roughly 1.4× Ramaco Resources, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs -27.7%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs -22.7%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Ramaco Resources, Inc. is a U.S.-based mining company focused on high-grade metallurgical coal production. It operates mining assets across the Appalachian region, supplying products to global steel manufacturing and industrial clients, with core operations centered on sustainable low-cost metallurgical coal extraction and distribution.
ESPR vs METC — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $121.0M |
| Net Profit | — | $-13.3M |
| Gross Margin | — | 15.8% |
| Operating Margin | 50.6% | -12.0% |
| Net Margin | — | -11.0% |
| Revenue YoY | 143.7% | -27.7% |
| Net Profit YoY | — | -5468.2% |
| EPS (diluted) | $0.32 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | — | ||
| Q3 25 | $87.3M | $121.0M | ||
| Q2 25 | $82.4M | $153.0M | ||
| Q1 25 | $65.0M | $134.7M | ||
| Q4 24 | $69.1M | $170.9M | ||
| Q3 24 | $51.6M | $167.4M | ||
| Q2 24 | $73.8M | $155.3M | ||
| Q1 24 | $137.7M | $172.7M |
| Q4 25 | — | — | ||
| Q3 25 | $-31.3M | $-13.3M | ||
| Q2 25 | $-12.7M | $-14.0M | ||
| Q1 25 | $-40.5M | $-9.5M | ||
| Q4 24 | — | $3.9M | ||
| Q3 24 | $-29.5M | $-239.0K | ||
| Q2 24 | $-61.9M | $5.5M | ||
| Q1 24 | $61.0M | $2.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | 15.8% | ||
| Q2 25 | — | 12.3% | ||
| Q1 25 | — | 15.2% | ||
| Q4 24 | — | 20.4% | ||
| Q3 24 | — | 19.5% | ||
| Q2 24 | — | 21.0% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | 50.6% | — | ||
| Q3 25 | -11.4% | -12.0% | ||
| Q2 25 | 8.6% | -9.1% | ||
| Q1 25 | -34.0% | -8.9% | ||
| Q4 24 | -6.4% | 3.7% | ||
| Q3 24 | -31.0% | 1.0% | ||
| Q2 24 | 3.5% | 3.5% | ||
| Q1 24 | 52.5% | 1.9% |
| Q4 25 | — | — | ||
| Q3 25 | -35.9% | -11.0% | ||
| Q2 25 | -15.4% | -9.1% | ||
| Q1 25 | -62.2% | -7.0% | ||
| Q4 24 | — | 2.3% | ||
| Q3 24 | -57.2% | -0.1% | ||
| Q2 24 | -83.9% | 3.6% | ||
| Q1 24 | 44.3% | 1.2% |
| Q4 25 | $0.32 | — | ||
| Q3 25 | $-0.16 | — | ||
| Q2 25 | $-0.06 | — | ||
| Q1 25 | $-0.21 | — | ||
| Q4 24 | $-0.14 | $0.06 | ||
| Q3 24 | $-0.15 | $-0.03 | ||
| Q2 24 | $-0.33 | $0.08 | ||
| Q1 24 | $0.34 | $0.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $193.8M |
| Total DebtLower is stronger | — | $116.3M |
| Stockholders' EquityBook value | $-302.0M | $526.9M |
| Total Assets | $465.9M | $849.7M |
| Debt / EquityLower = less leverage | — | 0.22× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | — | ||
| Q3 25 | $92.4M | $193.8M | ||
| Q2 25 | $86.1M | $28.1M | ||
| Q1 25 | $114.6M | $43.5M | ||
| Q4 24 | $144.8M | $33.0M | ||
| Q3 24 | $144.7M | $22.9M | ||
| Q2 24 | $189.3M | $27.6M | ||
| Q1 24 | $226.6M | $30.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $116.3M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $88.2M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-302.0M | — | ||
| Q3 25 | $-451.4M | $526.9M | ||
| Q2 25 | $-433.5M | $347.4M | ||
| Q1 25 | $-426.2M | $355.2M | ||
| Q4 24 | $-388.7M | $362.8M | ||
| Q3 24 | $-370.2M | $361.8M | ||
| Q2 24 | $-344.2M | $366.1M | ||
| Q1 24 | $-294.3M | $372.3M |
| Q4 25 | $465.9M | — | ||
| Q3 25 | $364.0M | $849.7M | ||
| Q2 25 | $347.1M | $674.6M | ||
| Q1 25 | $324.0M | $685.7M | ||
| Q4 24 | $343.8M | $674.7M | ||
| Q3 24 | $314.1M | $645.4M | ||
| Q2 24 | $352.3M | $659.2M | ||
| Q1 24 | $373.1M | $674.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.22× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.24× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $-1.4M |
| Free Cash FlowOCF − Capex | — | $-17.5M |
| FCF MarginFCF / Revenue | — | -14.5% |
| Capex IntensityCapex / Revenue | 0.0% | 13.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-24.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | — | ||
| Q3 25 | $-4.3M | $-1.4M | ||
| Q2 25 | $-31.4M | $-4.3M | ||
| Q1 25 | $-22.6M | $26.0M | ||
| Q4 24 | $-35.0M | $15.7M | ||
| Q3 24 | $-35.3M | $37.4M | ||
| Q2 24 | $-7.2M | $34.4M | ||
| Q1 24 | $53.8M | $25.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | $-17.5M | ||
| Q2 25 | — | $-19.8M | ||
| Q1 25 | — | $7.6M | ||
| Q4 24 | — | $5.1M | ||
| Q3 24 | $-35.5M | $25.6M | ||
| Q2 24 | $-7.3M | $20.3M | ||
| Q1 24 | $53.8M | $6.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | -14.5% | ||
| Q2 25 | — | -13.0% | ||
| Q1 25 | — | 5.6% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | -68.7% | 15.3% | ||
| Q2 24 | -9.9% | 13.1% | ||
| Q1 24 | 39.0% | 3.7% |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | 13.3% | ||
| Q2 25 | 0.0% | 10.2% | ||
| Q1 25 | 0.0% | 13.7% | ||
| Q4 24 | 0.0% | 6.2% | ||
| Q3 24 | 0.3% | 7.0% | ||
| Q2 24 | 0.1% | 9.1% | ||
| Q1 24 | 0.1% | 10.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 4.06× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 6.21× | ||
| Q1 24 | 0.88× | 12.40× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
METC
| Export Coal Revenues | $73.0M | 60% |
| Domestic Coal Revenues | $48.0M | 40% |
